But now Pfizer is betting that a radical new adult stem-cell treatment may be able to stave off diabetes-induced retina damage, a leading cause of blindness.
By reducing the panic-induced part of widening credit-spreads, the new liquidity tools mitigate the damage that dysfunctional credit markets would otherwise wreak on the economy.